注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
凯莱英医药集团(天津)股份有限公司是一家主要从事药物定制研发生产(CDMO)的中国公司。该公司的主营业务是化学药物的工艺开发、放大和商业化,产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司还从事药物制剂解决方案、生物合成解决方案和临床解决方案的提供。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Da Zhang | 41 | 2018 | CFO, Senior VP & Executive Director |
Rui Yang | 44 | 2011 | Co-CEO & Executive Director |
Liang Hong | 49 | 2011 | Executive VP & Executive Director |
Hao Hong | 67 | 2011 | Founder, Chairman & CEO |
Xinxin Zhi | 43 | 2011 | Chairman of the Supervisory Committee |
Kar Chung Lee | 42 | 2021 | Independent Non Executive Director |
Ye Song | 63 | 2011 | Non-Executive Director |
Shanshan Di | 37 | 2017 | Shareholder representative Supervisor |
Jingyi Hou | 40 | 2021 | Employee Representative Supervisor |
Stephane Caron | - | - | Member of Scientific Advisory Board |
Scott May | - | - | Member of Scientific Advisory Board |
Timothy F. Jamison | - | - | Member of Scientific Advisory Board |
Ting Zhang | 38 | 2021 | Non-Executive Director |
Patricia Alred | - | - | Member of Scientific Advisory Board |
Jin-Quan Yu | - | - | Member of Scientific Advisory Board |
Nicholas Turner | - | - | Member of Scientific Advisory Board |
Martin Eastgate | - | - | Member of Scientific Advisory Board |
Seble Wagaw | - | - | Member of Scientific Advisory Board |
Stephen L. Buchwald | - | - | Member of Scientific Advisory Board |
Phil S. Baran | 47 | - | Member of Scientific Advisory Board |
Xuejiao Sun | 41 | 2023 | Independent Non-Executive Director |
Xinyi Hou | 62 | 2024 | Independent Non-Executive Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核